Articles

All participants showed glycemic improvement but the structured behavioral group showed greater improvements compared to the other two treatment groups.…

Known as Juvisync (Merck), the new medication combines sitagliptin (Januvia, Merck), a dipeptidyl peptidase-4 (DPP-4) inhibitor used for glycemia control, with the cholesterol-lowering simvastatin.…

The investigational weight-loss combination of naltrexone standard release and bupropion standard release (Contrave) reduces the predicted 10-year risk of cardiovascular events, an analysis of four phase III trials showed.…

Even small changes in A1c and BP could significantly reduce the risk of CVD complications in people with type 2 diabetes….

It’s not clear why the relationship exists, and the findings do not prove that “screen time” itself worsens kids’ diabetes control but factors like obesity, exercise habits and family income did not explain the connection….

Conventional liver function tests may miss a diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes….

Poor oral health can lead to a greater risk of developing complications from type 2 diabetes, and problems such as inflammation from swollen gums can make diabetes worse, as well as having a negative impact on cardiovascular disease and oral cancer….

Food insulin index improves acute postprandial glycemia in type 1 diabetes versus carb counting….

A prospective analysis of body mass index (BMI) in 1957 children from ages 5 months to 8 years reveals that an “atypically elevated BMI trajectory” that leads to obesity is identifiable by age 3.5 years.…

Echo Therapeutics, a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system, announced positive results.…